Screener
Champions Oncology CSBR Q1 2026 earnings
Reported March 12, 2026 · After market close
Revenue$16.6MMiss by $54.0K
EPS-$0.02Miss by $0.11
Revenue estimate$16.6M
EPS estimate$0.09
Next report
Sep 14, 2026 (In 2 weeks)Revenue estimate$15.0M
EPS estimate-$0.01
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Champions Oncology report Q1 2026 earnings?
- Champions Oncology (CSBR) reported Q1 2026 earnings on March 12, 2026 after market close.
- What were Champions Oncology's Q1 2026 revenue and EPS?
- Champions Oncology reported revenue of $16.6M and eps of $-0.02 for Q1 2026.
- Did Champions Oncology beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $16.6M by $54.0K. EPS missed the consensus estimate of $0.09 by $0.11.
- How did Champions Oncology's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 2.8% from $17.0M a year earlier.
- Where can I find Champions Oncology's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001628280-26-017259) and the 10-Q periodic report (0001628280-26-017345) directly on SEC EDGAR. The filing index links above go to sec.gov.
